Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +14.75% | +14.75% | -81.53% |
14/05 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
10/05 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.53% | 140M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- RAPT Therapeutics' Q4 Loss Widens; Shares Down Pre-Bell